Infectious Diseases in Respiratory Medicine

Dear Colleagues,

We are pleased to invite you to contribute to this Special Issue, “Infectious Diseases in Respiratory Medicine”. Infectious diseases continue to represent a major cause of morbidity and mortality worldwide, with respiratory infections ranking among the most common and severe. The recent global experience with COVID-19 has highlighted the critical need for continued research into the diagnosis, treatment, and prevention of respiratory infections. Beyond emerging viral pandemics, bacterial, fungal, and mycobacterial respiratory infections remain highly prevalent, with substantial impact on healthcare systems, patient quality of life, and long-term outcomes. Advancing our understanding in this field is therefore essential for improving patient care and public health.

This Special Issue aims to bring together cutting-edge research and expert perspectives on infectious diseases affecting the respiratory system. It will cover diverse aspects of pathogenesis, diagnostics, therapeutics, and prevention strategies. The focus of this Special Issue aligns closely with the scope of the journal, which emphasizes advances in the understanding and management of respiratory disorders. We expect this collection to be of great interest to clinicians, researchers, and policymakers involved in respiratory and infectious disease medicine.

In this Special Issue, we welcome original research articles, systematic reviews, meta-analyses, and narrative reviews. Research areas may include, but are not limited to, the following themes:

• Viral respiratory infections (e.g., influenza, SARS-CoV-2, RSV);
• Bacterial pneumonias and antimicrobial resistance in respiratory medicine;
• Tuberculosis and non-tuberculous mycobacterial lung disease;
• Opportunistic infections in immunocompromised hosts;
• Fungal respiratory infections (e.g., aspergillosis, endemic mycoses);
• Advances in rapid diagnostics and molecular testing;
• Vaccines and preventive strategies in respiratory infectious diseases;
• Host immune response and pathophysiology of respiratory infections;
• Emerging pathogens and global health perspectives;
• Infection control and public health implications.

We look forward to receiving your valuable contributions.

Sincerely,
Dr. Kay Choong See
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Advances in Respiratory Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.